Table 1 Patients’ characteristics
From: Prognostic factors for survival of women with unstable spinal bone metastases from breast cancer
Number | Percent | ||
|---|---|---|---|
Age (mean, SD) | 60.8 (±12.4) | ||
KPS | ≤70 | 35 | 38.0 |
>70 | 57 | 62.0 | |
Localization | thoracic | 67 | 72.8 |
lumbar | 25 | 27.2 | |
Chemotherapy before RT | yes | 53 | 57.6 |
no | 39 | 42.4 | |
Radiological response at 3 months after RT | yes | 29 | 31.5 |
no | 63 | 68.5 | |
Radiological response at 6 months after RT | yes | 42 | 45.7 |
no | 50 | 54.3 | |
Bisphosphonates | yes | 85 | 92.4 |
no | 7 | 7.6 | |
Distant metastases | brain | 6 | 6.5 |
lung | 13 | 14.1 | |
liver | 19 | 20.6 | |
skin | 2 | 2.2 | |
Number of metastases | solitary | 33 | 35.9 |
multiple | 59 | 64.1 | |
Orthopedic corset | yes | 33 | 35.9 |
no | 59 | 64.1 | |
Pathological fracture before RT | yes | 6 | 6.5 |
no | 86 | 93.5 | |
Molecular phenotype | luminal A | 55 | 59.8 |
luminal B | 8 | 8.7 | |
HER2 | 9 | 9.8 | |
triple negative | 20 | 21.7 | |